25 Mar 2009 07:00
Trading Update
IDS, a leading producer of diagnostic testing kits, announces that revenue for the year ending 31 March 2009 is expected to be circa 43% ahead of last year's numbers (y/e 31 March 2008: £18.66m). Revenue on a continuing operations basis is expected to increase by circa 47%, with revenue from the divested haematology business for the 9 month period to 31 December 2008 amounting to £2.45m (y/e 31 March 2008: £2.19m).
Costs remain under control and trading in all of the Group's main territories has increased year on year as well as across the Group's key products. Sales into the USA, France and Germany have seen significant growth this year.
Profits before tax prior to a net exceptional gain for the year ending 31 March 2009 are expected to be in line with expectations.
Enquiries:
| IDS | Tel: 0191 519 0660 |
| Roger Duggan, CEO | |
| Paul Hailes, Finance Director | www.idsplc.com |
| Parkgreen Communications Ltd | Tel: 020 7933 8787 |
| Paul McManus | Mob: 07980 541 893 |
| paul.mcmanus@parkgreenmedia.com | |
| Oriel Securities Ltd | Nominated Advisor and joint broker |
| Richard Crawley or Gareth Price | Tel: 020 7710 7600 |
| Teathers | Joint broker |
| Shaun Dobson | Tel: 020 7426 9582 |
IDH.L (IDH)